CLINICAL_TRIALS
trial_result
· 2021-11-18
Clinical Trial Update: The BCD-089 (aIL6R) in Patients With Active Rheumatoid Arthritis [Phase 2]
Summary
Phase 2 clinical trial update for BCD-089 (aIL6R) in seropositive rheumatoid arthritis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biocad | Conditions: Seropositive RA | Phase 2 | Status: COMPLETED